Patrick Harrison Carroll - 01 Mar 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
01 Mar 2023
Net transactions value
-$244,027
Form type
4
Filing time
03 Mar 2023, 15:33:34 UTC
Previous filing
11 Aug 2022
Next filing
17 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale $244,027 -20,857 -17% $11.70 102,862 01 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Award $0 +130,378 $0.000000 130,378 01 Mar 2023 Class A Common Stock 130,378 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.615 - $11.84. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.